On Wednesday 13th October, we hosted our Annual All Stakeholder Briefing, focusing on Early diagnosis for rare and less common cancers:...

Cancer52's All Stakeholder Briefing will take place (virtually) on Wednesday 13th October 2021 from 09:30am until 12:30pm. The focus for...

We are pleased to have partnered with Pfizer to launch the Do You C Us? Campaign. The Do You C Us? Campaign aims to raise awareness of...

A review of the work of 13 Cancer52 charities undertaken to provide psychosocial support to people with rare and less common cancers...

The final response, including the full list of charities who signed up, has now been submitted. If you would like to see a copy of this...

With help from its member charities, Cancer52 ran a second survey of people with rare and less common cancers from early December 2020 to...

Cancer52 is delighted to present its Annual Review 2019 / 20. This report not only shows the standing of the organisation prior to the...

In December 2020, Cancer52 submitted a consultation response from Cancer52 to the NICE Methods Review. The response was supported by 23...

The Health and Social Care Select Committee have published their report on the inquiry 'Delivering core NHS and care services during the...

Cancer52 is proud to have joined forces with 19 other rare and less common cancer charities in a major new fundraising campaign that has...